PLPC VP exercises 1,750 options, surrenders shares

PREFORMED LINE PRODUCTS CO vice president of US manufacturing Assaad A. Morcos reported a compensation-related stock transaction.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

PREFORMED LINE PRODUCTS CO vice president of US manufacturing Assaad A. Morcos reported a compensation-related stock transaction. He exercised employee stock options to acquire 1,750 common shares at $132.4000 per share, then disposed of those 1,750 common shares to the issuer at $260.3400 per share, leaving no directly held common shares after the transactions. He continues to hold restricted stock units that are deliverable in 681 and 407 underlying common shares, which vest three years from their grant dates. Footnotes explain that the original 7,500-option grant vests in tranches through December 2027 with a 10-year term.

Insider Trade Summary

1,750 shares exercised/converted

Exercise 5 txns

Insider Morcos Assaad A

Role VP, US Manufacturing

Type	Security	Shares	Price	Value
Exercise	Employee stock option (right to buy)	1,750	$132.40	$232K
Exercise	Common Shares, $2 par value per share	1,750	$132.40	$232K
Disposition	Common Shares, $2 par value per share	1,750	$260.34	$456K
holding	Restricted stock units	--	--	--
holding	Restricted stock units	--	--	--

Holdings After Transaction: Employee stock option (right to buy) — 4,750 contracts (Direct); Common Shares, $2 par value per share — 0 shares (Direct); Restricted stock units — 1,088 contracts (Direct)

Footnotes (2)

F1. On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.
F2. Restricted stock units vest 3 years from the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PLPC executive Assaad A. Morcos report on this Form 4?

Assaad A. Morcos reported exercising employee stock options to acquire 1,750 PREFORMED LINE PRODUCTS CO common shares at $132.4000 each, then disposing of those 1,750 common shares back to the issuer at $260.3400 per share on the same date, March 10, 2026.

Did the PLPC executive buy or sell shares in the open market?

The filing shows no open-market purchases or sales. Morcos exercised stock options and then disposed of 1,750 common shares to the issuer, coded as a disposition to issuer, rather than an open-market transaction, based on the Form 4 transaction codes and descriptions.

How many PREFORMED LINE PRODUCTS (PLPC) shares does Morcos hold after this Form 4?

After the reported transactions, Morcos holds zero common shares directly. However, he retains restricted stock units tied to 681 and 407 underlying common shares, which remain outstanding as derivative positions, vesting three years from their respective grant dates according to the footnotes.

What stock options did the PLPC Form 4 say were exercised and at what price?

The Form 4 shows an employee stock option exercise covering 1,750 underlying common shares at an exercise price of $132.4000 per share. These options were part of a 7,500-option grant awarded on December 11, 2024, which vests in tranches through December 11, 2027.

What vesting details were disclosed for Assaad A. Morcos’s PLPC equity awards?

The filing notes a 7,500-option grant where 3,750 options vested on December 11, 2025, another 1,875 will vest on December 11, 2026, and 1,875 on December 11, 2027, with a 10-year term. Restricted stock units vest three years from each grant date.

What restricted stock units does the PLPC executive still hold after the transactions?

Morcos continues to hold restricted stock units linked to 681 and 407 underlying PREFORMED LINE PRODUCTS CO common shares. These RSUs have a zero exercise price and are scheduled to vest three years after their respective grant dates, as described in the Form 4 footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/13/2026 - 04:51 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morcos Assaad A

(Last)

(First)

(Middle)

660 BETA DRIVE

(Street)

CLEVELAND

44143

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PREFORMED LINE PRODUCTS CO [ PLPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, US Manufacturing

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares, $2 par value per share	03/10/2026	03/10/2026	M		1,750⁽¹⁾	A	$132.4	1,750	D
Common Shares, $2 par value per share	03/10/2026	03/10/2026	D		1,750	D	$260.34	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee stock option (right to buy)	$132.4	03/10/2026	03/10/2026	M			1,750	⁽¹⁾	⁽¹⁾	Common Shares, $2 par value per share	1,750	$132.4	4,750	D
Restricted stock units	$0							⁽²⁾	⁽²⁾	Common shares, $2 par value	681		681	D
Restricted stock units	$0							⁽²⁾	⁽²⁾	Common shares, $2 par value	407		407	D

Explanation of Responses:

1. On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.

2. Restricted stock units vest 3 years from the date of grant.

Remarks:

	/s/ Caroline S Vaccariello, by power of attorney	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR